Developpement of novel therapies

The purpose of the 4th research axis of the LIIC team is to develop a new anti-cancer therapy using a kinase inhibitor still not used in the clinic. The use of this compound involves the collaboration with members of the Chemistry Department of the University of Burgundy (ICMUB).